<?xml version="1.0" encoding="UTF-8"?>
<p id="p0015">The frequency of thyroid patients is in constant rise in Algeria affecting mainly adult female; according to 
 <xref rid="b0375" ref-type="bibr">WHO (2018)</xref>, 2.103 new thyroid cancer cases were recorded in Algeria during 2018 among which 1.714 were women (81.5%). Clinical and epidemiological studies in Algeria have demonstrated the predominance of the papillary form (60% of cases) against vesicular form (40%). The treatment of differentiated thyroid cancer, most often revealed by a goiter (85%), consists of large thyroid surgery (91%) with lymph node dissection and ablative iratherapy (89%). The survival rate at 5, 15 and 30Â years, depending on whether it is papillary or vesicular carcinoma, is respectively 95%, 94% and 79% versus 82%, 67% and 63% (
 <xref rid="b0050" ref-type="bibr">Benouis et al., 2017</xref>).
</p>
